GB0718542D0 - Targeted modulation of gene expression - Google Patents

Targeted modulation of gene expression

Info

Publication number
GB0718542D0
GB0718542D0 GBGB0718542.4A GB0718542A GB0718542D0 GB 0718542 D0 GB0718542 D0 GB 0718542D0 GB 0718542 A GB0718542 A GB 0718542A GB 0718542 D0 GB0718542 D0 GB 0718542D0
Authority
GB
United Kingdom
Prior art keywords
gene expression
targeted modulation
targeted
modulation
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0718542.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB0718542.4A priority Critical patent/GB0718542D0/en
Publication of GB0718542D0 publication Critical patent/GB0718542D0/en
Priority to US12/679,208 priority patent/US20110212058A1/en
Priority to PCT/GB2008/003211 priority patent/WO2009037490A1/en
Priority to CN200880117264A priority patent/CN101868543A/zh
Priority to EP08806365.6A priority patent/EP2205739B1/en
Priority to JP2010525439A priority patent/JP5756631B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0718542.4A 2007-09-22 2007-09-22 Targeted modulation of gene expression Ceased GB0718542D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0718542.4A GB0718542D0 (en) 2007-09-22 2007-09-22 Targeted modulation of gene expression
US12/679,208 US20110212058A1 (en) 2007-09-22 2008-09-22 Targeted modulation of gene expression
PCT/GB2008/003211 WO2009037490A1 (en) 2007-09-22 2008-09-22 Targeted modulation of gene expression
CN200880117264A CN101868543A (zh) 2007-09-22 2008-09-22 基因表达的靶向调节
EP08806365.6A EP2205739B1 (en) 2007-09-22 2008-09-22 Targeted modulation of gene expression
JP2010525439A JP5756631B2 (ja) 2007-09-22 2008-09-22 遺伝子発現の標的調節

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0718542.4A GB0718542D0 (en) 2007-09-22 2007-09-22 Targeted modulation of gene expression

Publications (1)

Publication Number Publication Date
GB0718542D0 true GB0718542D0 (en) 2007-10-31

Family

ID=38670367

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0718542.4A Ceased GB0718542D0 (en) 2007-09-22 2007-09-22 Targeted modulation of gene expression

Country Status (6)

Country Link
US (1) US20110212058A1 (enExample)
EP (1) EP2205739B1 (enExample)
JP (1) JP5756631B2 (enExample)
CN (1) CN101868543A (enExample)
GB (1) GB0718542D0 (enExample)
WO (1) WO2009037490A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013022092A1 (ja) * 2011-08-11 2013-02-14 学校法人新潟科学技術学園新潟薬科大学 ヒト血液がん細胞のアポトーシスを誘導するヘプタマー型スモールガイド核酸
GB201117482D0 (en) * 2011-10-11 2011-11-23 Univ Dundee Targetiing of miRNA precursors
LT3198033T (lt) 2014-09-26 2022-05-10 Janssen Pharmaceutica Nv Fgfr mutantinių genų rinkinių panaudojimas identifikuojant vėžiu sergančius pacientus, kurie reaguos į gydymą fgfr inhibitoriumi
RU2018124657A (ru) 2015-12-09 2020-01-09 Эксижн Биотерапевтикс, Инк. Способы редактирования генов и композиции для устранения риска активации вируса jc и пмл (прогрессирующая мультифокальная лейкоэнцефалопатия) во время иммуносупрессивной терапии
CA3084810A1 (en) * 2017-12-08 2019-06-13 University Of Connecticut Compositions and methods for treating disorders of genomic imprinting
AU2019243946B2 (en) * 2018-03-27 2025-03-06 Proqr Therapeutics Ii B.V. Nucleic acid molecules for pseudouridylation
WO2024102659A1 (en) * 2022-11-08 2024-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Directed acetylation of mrna through engineered snorna adapters
CN116694759B (zh) * 2023-02-17 2023-12-15 中国人民解放军军事科学院军事医学研究院 Scarna12基因调节细胞增殖与存活中的应用
CN116525001A (zh) * 2023-04-27 2023-08-01 西安交通大学 一种基于深度学习的rna修饰位点预测模型的构建方法

Also Published As

Publication number Publication date
US20110212058A1 (en) 2011-09-01
JP5756631B2 (ja) 2015-07-29
EP2205739A1 (en) 2010-07-14
WO2009037490A1 (en) 2009-03-26
JP2010539895A (ja) 2010-12-24
CN101868543A (zh) 2010-10-20
EP2205739B1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
IL246770B (en) Modulation of hsp47 expression
SI3225251T1 (sl) Modulacija aktivnosti pronevrotrofinov
EG25742A (en) Photobioreactor
EP2462230A4 (en) METHOD AND COMPOSITIONS FOR TARGETED GENE MODIFICATION
EP2183376A4 (en) ENZYMATIC MODIFICATION OF OILS
IL212568A0 (en) Modulators of cxcr7
GB0718542D0 (en) Targeted modulation of gene expression
IL212119A0 (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
GB0816778D0 (en) Gene silencing
ZA201006797B (en) Expression-linked gene discovery
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
GB0820698D0 (en) Uses of immunomodulators
ZA201005430B (en) Selection of targeted advertisements
ZA201000225B (en) Treatment of depression
IL226536A (en) DNA position-oriented change
GB0804721D0 (en) Enzyme
GB0701722D0 (en) Inhibition of gene expression
GB0803628D0 (en) Enzyme
GB0809627D0 (en) Targeted gene therapy
GB0807632D0 (en) Osteoathritis disease gene modulation
GB0909239D0 (en) Targeted gene therapy
GB0811149D0 (en) Gene
EP2318527A4 (en) METHODS FOR TARGETING GENES
AU2008902214A0 (en) Modulation of Flightness I
AU2007901763A0 (en) Targeted distribution of advertising

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)